SCHEMBL7585252

SCHEMBL7585252

CSc1nnc2cc(-c3c(Cl)cccc3Cl)c(=O)[nH]c2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 6/20 0.38
▸ SRC P12931 6/20 0.38
▸ LMNA P02545 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ GUSB P08236 1/20 0.36
▸ PSEN1 P49768 1/20 0.36
▸ PSEN2 P49810 1/20 0.36
▸ APH1B Q8WW43 1/20 0.36
▸ NCSTN Q92542 1/20 0.36
▸ APH1A Q96BI3 1/20 0.36
▸ PSENEN Q9NZ42 1/20 0.36
▸ PDE3B Q13370 1/20 0.36
▸ PDE3A Q14432 1/20 0.36
▸ PARP1 P09874 1/20 0.35
▸ ABL1 P00519 2/20 0.34
▸ STK10 O94804 2/20 0.34
▸ EGFR P00533 2/20 0.34
▸ SLK Q9H2G2 2/20 0.34
▸ BMPR1B O00238 1/20 0.34
▸ STK25 O00506 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7584087 0.81 GUSB (0.39) FGFR1SRCGUSBPDE3BPDE3A
SCHEMBL29536840 0.80 FGFR1 (0.45) FGFR1SRCPSEN1PSEN2APH1B
SCHEMBL5659394 0.80 FGFR1 (0.45) FGFR1SRCPSEN1PSEN2APH1B
SCHEMBL19817042 0.69 SIK2 (0.40) FGFR1SRCPSEN1PSEN2APH1B
SCHEMBL14370847 0.68 SIK2 (0.47) LMNAGUSBABL1STK10SLK
SCHEMBL29536534 0.68 SIK2 (0.47) LMNAGUSBABL1STK10SLK
SCHEMBL5619944 0.65 SRC (0.56) FGFR1SRCABL1EGFRPDGFRB
SCHEMBL16986359 0.65 DHFR (0.41) FGFR1SRCGUSBPDE3BPDE3A
SCHEMBL14875515 0.64 WEE1 (0.47) FGFR1SRCLMNAHPGDPSEN1
SCHEMBL14161489 0.64 RIPK2 (0.46) FGFR1SRCLMNAABL1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076396-A2 COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES SMITHKLINE BEECHAM CORPORATION (US) 2002-10-03 — — WO disclosed
Send feedback